Closing Bell: Biosyent Inc down on Tuesday (RX)

In today's trading, Biosyent Inc shares opened at $9.95 and closed at $10.00. It traded at a low of $9.70 to a high of $10.00.

The price decreased -0.89 percent from the previous day's close of $10.09.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -3.00% at 5186.33, the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

Trading volume was 2,927 on 11 total trades, while having an average volume of 8,206 over the last 5-days.

The TSX-V market on the whole today saw 3,772 price advancers against 1,443 declines and 86 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $10.75 (June 21,2024) and low as $7.55 (August 08,2023). Moreover, in the last 12 months, Biosyent Inc's shares have advanced 32.45 percent, while they have boosted 8.46% this year.

It announced a 0.04 dividend on May 16/24, with an May 31/24 ex-date and June 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $116.89 million on a float of 11,584 shares outstanding. Its annual EPS is $0.58.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc's consensus rating is "Moderate Buy" based on 1 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..